1-((S)-1-(((S)-2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methyl)piperidin-3-yl)-4-phenylimidazolidin-2-one

ID: ALA5202684

PubChem CID: 138621575

Max Phase: Preclinical

Molecular Formula: C23H27N3O3

Molecular Weight: 393.49

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C1NC(c2ccccc2)CN1[C@H]1CCCN(C[C@H]2COc3ccccc3O2)C1

Standard InChI:  InChI=1S/C23H27N3O3/c27-23-24-20(17-7-2-1-3-8-17)15-26(23)18-9-6-12-25(13-18)14-19-16-28-21-10-4-5-11-22(21)29-19/h1-5,7-8,10-11,18-20H,6,9,12-16H2,(H,24,27)/t18-,19-,20?/m0/s1

Standard InChI Key:  BDWMLCZMMGHSMH-NFBCFJMWSA-N

Molfile:  

 
     RDKit          2D

 29 33  0  0  0  0  0  0  0  0999 V2000
   -2.8876    1.2665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1730    1.6790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4585    1.2665    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7442    1.6790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7442    2.5040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0297    2.9165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6847    2.5040    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3991    2.9165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1136    2.5040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1136    1.6790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3991    1.2665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3991    0.4415    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7317   -0.0433    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0528    0.2115    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9867   -0.8279    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8117   -0.8279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2966   -1.4954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9610   -2.2491    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4460   -2.9165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2663   -2.8302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6020   -2.0764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1171   -1.4091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0666   -0.0433    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6847    1.6790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4585    2.9165    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1730    2.5040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8876    2.9165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6020    2.5040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6020    1.6790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  1
  6  7  1  0
  8  7  1  0
  9  8  1  0
 10  9  1  0
 11 10  1  0
 11 12  1  6
 13 12  1  0
 13 14  2  0
 15 13  1  0
 16 15  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 22 17  2  0
 21 22  1  0
 23 16  1  0
 23 12  1  0
 24 11  1  0
  7 24  1  0
  5 25  1  0
 26 25  1  0
  2 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29  1  2  0
M  END

Alternative Forms

  1. Parent:

    ALA5202684

    ---

Associated Targets(Human)

ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2C Tclin Alpha-2c adrenergic receptor (4876 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 393.49Molecular Weight (Monoisotopic): 393.2052AlogP: 3.06#Rotatable Bonds: 4
Polar Surface Area: 54.04Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.48CX Basic pKa: 7.63CX LogP: 2.78CX LogD: 2.35
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.87Np Likeness Score: -0.45

References

1. Wang S, Haikarainen A, Pohjakallio A, Sipilä J, Kaskinoro J, Juhila S, Jalava N, Koskinen M, Vesajoki M, Kumpulainen E, Pystynen J, Koskelainen T, Holm P, Din Belle D..  (2022)  2,3-Dihydrobenzo-dioxine piperidine derivatives as potent and selective α2c antagonists.,  69  [PMID:35569686] [10.1016/j.bmcl.2022.128783]

Source